HIKALPharmaceuticals
Hikal Ltd — Quarterly Results & Earnings
₹147.08
-6.80%
Profit Growth YoY-290.71%Latest quarter
Sales Growth YoY-29.68%Latest quarter
Sales CAGR 5Y4.29%5 year compound
Profit CAGR 5Y-0.94%5 year compound
📋
Quarterly Performance
YoY Profit Growth-290.71%
🔴 Significant decline
YoY Sales Growth-29.68%
🔴 Significant decline
OPM 5Y Average
16.25%Operating profit margin
EPS Growth 5Y
-0.94%Interest Coverage
1.21Higher = safer debt servicing
ROE
7.38%ROCE
9.85%💡
Growth Analysis
Hikal Ltd reported YoY profit growth of -290.71% and revenue growth of -29.68% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 4.29% and profits at -0.94% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Hikal Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.